image

Novo Nordisk A/S - Company Information

Novo Nordisk A/S is a global healthcare company engaged in the discovery, development, manufacturing, and marketing of pharmaceutical products, focusi...Read more

Biotech & Pharmaceuticals
  • icon
    Headquarters

    Copenhagen, Capital Region, Denmark

  • icon
    Contact

    Unlock contact

  • icon
    Linkedin

    linkedin icon

  • icon
    Company Size

    10,000+

  • icon
    Stock Symbol

    NVO

  • icon
    Website

    novonordisk.com

  • icon
    Type

    Public

icon

Novo Nordisk A/S Technology Stack

Find prospects by the technologies they use. Use this section to learn more about key technologies and tools, tracked by 6sense, used by Novo Nordisk A/S

image

Azure SQL

thumbs_up

thumbs_down

Azure SQL is a relational database platform that is present in the cloud where users can h...

See more technologies

Novo Nordisk A/S Employee Profiles

Are you looking for the decision-makers at Novo Nordisk A/S? Get their email address, phone numbers, and other details from Linkedin or any website. Install and uncover Novo Nordisk A/S’s employee details in less than 30 secs.

Sign-up for 6sense Revenue AI™ for Sales

To find emails, direct dials, and more for prospects across the web.

Sign Up Today

Novo Nordisk A/S Competitors

Discover Novo Nordisk A/S alternatives or similar companies to benchmark and competitors market analysis. Build a competitive intelligence sales and marketing strategy based on the data and stand out in the market.

image

Rakuten, Inc.

  • icon
    Total Employees

    500 - 999

  • icon
    Location

    Tokyo

  • icon
    Website

    rakuten.com

  • icon
    Type

    Public

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    linkedin icon

image

Safe Online

  • icon
    Total Employees

    20 - 49

  • icon
    Location

    Copenhagen

  • icon
    Website

    bysafeonline.com

  • icon
    Type

    Private

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    linkedin icon

image

Garnisons Kirke Og Kirkegård

  • icon
    Total Employees

    20 - 49

  • icon
    Location

    Copenhagen

  • icon
    Website

    garnisonskirkegaard.dk

  • icon
    Type

    N/A

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    N/A

image

MXNEY.io

  • icon
    Total Employees

    20 - 49

  • icon
    Location

    Copenhagen

  • icon
    Website

    mxney.io

  • icon
    Type

    Private

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    linkedin icon

image

Change Board Member

  • icon
    Total Employees

    0 - 9

  • icon
    Location

    Copenhagen

  • icon
    Website

    legalcrossborder.com

  • icon
    Type

    Partnership

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    linkedin icon

Download the 6sense Chrome Extension to get verified contact data of Novo Nordisk A/S employees

Install Now
Company Logo

Novo Nordisk A/S News & Press Releases

Sales prospecting needs to be timely and appropriate for the person and organization you are contacting. Following the most recent company news, alerts, and updates about the leads you are currently working on is the simplest and most convenient way to stay on top of them. Here are Novo Nordisk A/S latest news, alerts and updates.

Wegovy maker Novo Nordisk signs research partnerships with U.S. biotech firms

Blockbuster weight-loss drug maker Novo Nordisk announced on Thursday research collaborations with two U.S. biotech firms, part of its efforts to stay ahead in big pharma's race to develop more treatments for cardiometabolic diseases.

Date Icon

4 Jan 2024

Diving into CVD? Novo Nordisk to acquire KBP’s hypertension drug for $1.3B

Danish obesity and diabetes drugmaker Novo Nordisk A/S is set to acquire the Singapore-based KBP Biosciences Co. Ltd.™s hypertension drug, ocedurenone (KBP-5074), for potentially $1.3 billion, creating a platform to increase its reach in the cardiovascular (CV) landscape beyond a crowding obesity market.

Date Icon

17 Oct 2023

Novo Nordisk to acquire ocedurenone for uncontrolled hypertension from KBP Biosciences

Novo Nordisk A/S and KBP Biosciences PTE., Ltd. today announced that Novo Nordisk has agreed to acquire ocedurenone for uncontrolled hypertension with potential application in cardiovascular and kidney disease from KBP Biosciences for up to 1.

Date Icon

16 Oct 2023

Novo Nordisk to acquire obesity drug developer Inversago

Inversago is a privately owned company which develops therapies pitched at people with obesity, diabetes and metabolic disorders, the Novo Nordisk said in its second-quarter report. Inversago's lead asset is INV-202,

Date Icon

11 Aug 2023

Novo Nordisk plans to acquire Canadian obesity drug maker Inversago

Drug manufacturer Novo Nordisk announced Thursday that it will acquire Inversago Pharma, a Montreal-based company that develops potential treatments for obesity, if certain research conditions are met,

Date Icon

10 Aug 2023

Completion of Novo Nordisk's Acquisition of a Controlling Stake in BIOCORP

ISSOIRE, France, August 04, 2023--(BUSINESS WIRE)--Regulatory News: Following the announcement of the planned acquisition of BIOCORP Production SA (FR0012788065 - ALCOR) ("BIOCORP") by NOVO NORDISK (DK0060534915 - Novo-B), a leading global healthcare ...

Date Icon

6 Aug 2023

FAQs for Novo Nordisk A/S

Explore frequently asked questions about Novo Nordisk A/S’s business, including founding details, header quarters, information on technology stack, industry listing, and other details.

What is Novo Nordisk A/S's official website?

The official website of Novo Nordisk A/S is novonordisk.com You can find their contact number, email address, and headquarters by clicking here.

faq icon

How many employees are working at Novo Nordisk A/S?

faq icon

What industry is Novo Nordisk A/S in?

faq icon

What is Novo Nordisk A/S's tech stack?

faq icon

Where are Novo Nordisk A/S's headquarters?

faq icon

Get instant access to B2B contact data across the web

Sign Up Today
6sense Logo
social iconssocial iconssocial iconssocial icons
MarketingAccount IdentificationIntent DataData Enrichment & ManagementPredictive AnalyticsOrchestrations & WorkflowsAudience BuildingAdvertisingConversational EmailPipeline IntelligenceIntegrations
SolutionsBusiness ServicesFinancial ServicesTransportation & LogisticsManufacturingTechnologyCustomersMeet Our CustomersCustomer StoriesCustomer ReviewsRevCityKnowledge Base

Company

AboutLeadership TeamCareersNewsroomCommunity

Browse 6sense Data

TechnographicsComparing TechnologiesCompany SearchPeople Search
TermsPrivacy PolicyPrivacy CenterDo Not Sell or Share My Personal Information

© 2024 6sense